1 St Source Bank Amgen Inc Transaction History

1 St Source Bank

$1.71 Billion
Q2 2024

A detailed history of 1 St Source Bank transactions in Amgen Inc stock. As of the latest transaction made, 1 St Source Bank holds 2,913 shares of AMGN stock, worth $920,508. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,913

Previous 2,912 0.03%

Holding current value

$920,508

Previous $827,000 10.04%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.03%	2,913 $910,000
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $7,797 - $9,412	-29 Reduced 0.99%	2,912 $827,000
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $59,066 - $66,634	-231 Reduced 7.28%	2,941 $847,000
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $52,913 - $65,693	-242 Reduced 7.09%	3,172 $852,000
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $15,641 - $18,496	-73 Reduced 2.09%	3,414 $757,000
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $1,128 - $1,376	-5 Reduced 0.14%	3,487 $842,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $21,070 - $26,772	-92 Reduced 2.57%	3,492 $917,000
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $44,443 - $50,123	198 Added 5.85%	3,584 $808,000
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $38,759 - $43,132	-168 Reduced 4.73%	3,386 $824,000
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $20,830 - $23,044	95 Added 2.75%	3,554 $859,000
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $1,591 - $1,820	-8 Reduced 0.23%	3,459 $778,000
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $424 - $497	2 Added 0.06%	3,467 $737,000
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $35,737 - $39,648	153 Added 4.62%	3,465 $845,000
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $19,084 - $22,239	-86 Reduced 2.53%	3,312 $824,000
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $27,047 - $32,208	125 Added 3.82%	3,398 $781,000
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $5,162 - $5,740	-22 Reduced 0.67%	3,273 $832,000
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $35,210 - $43,207	178 Added 5.71%	3,295 $777,000
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $57,770 - $76,618	-317 Reduced 9.23%	3,117 $632,000
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $6,622 - $8,512	-35 Reduced 1.01%	3,434 $828,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $30,817 - $36,925	-177 Reduced 4.85%	3,469 $671,000
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $16,670 - $19,541	-100 Reduced 2.67%	3,646 $672,000
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $112,501 - $126,813	622 Added 19.91%	3,746 $712,000
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $20,337 - $23,740	114 Added 3.79%	3,124 $608,000
Q3 2018 Oct 31, 2018	BUY	$185.29 - $208.89 $6,485 - $7,311	35 Added 1.18%	3,010 $624,000
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $70,405 - $79,080	-424 Reduced 12.47%	2,975 $549,000
Q1 2018 Apr 24, 2018	SELL	$169.43 - $198.0 $21,348 - $24,948	-126 Reduced 3.57%	3,399 $579,000
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $589,697 - $673,275	3,525	3,525 $657,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1 St Source Bank, based on Form 13F filings with the SEC.

News

Stay updated on 1 St Source Bank with notifications on news.

Account